SION (Sionna Pharma) סך נכסי הפעילות העסקית

Sionna Therapeutics Inc (SION) is led by top scientists in the field of hereditary pathology therapies who maintain successful interactions with regulatory bodies. The technological stack is complemented by automated systems for high-precision compound analysis, which accelerate the drug discovery process. The company is developing treatments for cystic fibrosis, aiming for leadership in this segment. As illustrated on the chart, the market value of the asset is 317.61.

The financial stability assessment of Sionna Therapeutics Inc (SION) is based on the aggregate resources controlled by the issuer to implement research and development programs. This market value, calculated inversely via ROA, reflects the future potential of assets, where fluctuations in total equity and liabilities confirm the company's ability to retain a unique staff of geneticists and cystic fibrosis researchers through a robust material, technical, and intellectual base.